A short wellness post arguing that the scale misses part of the picture for people on semaglutide or tirzepatide. Light on specifics.
Recap by typeshit. Post by @gloandsparkle on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
In a 39-person randomized pilot, people on the support programs regained about 3.6% of body weight in four months, versus roughly 11% with usual care.
She credits protein, fiber, water and workouts alongside the drug, and shares how she feels plus a routine that shifts when she travels.
Loading…